Tobacco and Public Health - TCSC Indonesia

476
SMOKING AND CERVICAL NEOPLASIA
Mancini, R., et al. (1999). Polycyclic aromatic hydrocarbon-DNA adducts in cervical smears of
smokers and non-smokers. Gynecol Oncol, 75, 68–71.
Mandelblatt, J. S., et al. (1992). Association between HIV infection and cervical neoplasia: implications
for clinical care of women at risk for both conditions. AIDS, 6, 173–8.
Margetts, B. and Jackson, A. (1993). Interactions between people’s diet and their smoking habits: the
dietary and nutritional survey of British adults. BMJ, 307, 1381–4.
Matorras, R., et al. (1991). Human immunodeficiency virus-induced immunosuppression: a risk
factor for human papillomavirus infection. Am J Obstet Gynecol, 164, 42–4.
McArdle, J. P. and Muller,H. K. (1986). Quantitative assessment of Langerhans’ cells in human
cervical intraepithelial neoplasia and wart virus infection. Am J Obstet Gynecol, 154, 509–15.
McCann, M. F., et al. (1992). Nicotine and cotinine in the cervical mucus of smokers, passive smokers
and nonsmokers. Cancer Epidemiol, Biomarkers and Prev, 1, 125–9.
Miller, L.G., et al. (1982). Reversible alterations in immunoregulatory T cells in smoking. Chest, 5, 527–9.
Mills, C. M., et al. (1993). Altered inflammatory responses in smokers. BMJ, 307, 911.
Moreno, V., et al. (2002). Effect of oral contraceptives on risk of cervical cancer in women with
human papillomavirus infection: the IARC multicentric case-control study. Lancet, 359, 1085–92.
Morelli, A. E., et al. (1992). Assessment by planimetry of Langerhans’ cell density in penile epithelium
with human papillomavirus infection. J Urol, 147, 1268–73.
Morelli, A. E., et al. (1993). Relationship between types of human papillomavirus and Langerhans’
cells in cervical condyloma and intraepithelial neoplasia. Am J Clin Path, 99, 200–6.
Morris, H. H. B., et al. (1983). Langerhans’ cells in human cervical epithelium: effects of wart virus
infection and intraepithelial neoplasia. Br J Obstet Gynaecol, 90, 412–20.
Morrison, E. A. B., et al. (1991). Human papillomavirus infection and other risk factors for cervical
neoplasia: A case-control study. Int J Cancer, 49, 6–13.
Moscicki, A. B., et al. (2001). Risks for incident human papillomavirus and low grade squamous
intraepithelial lesion development in young females. JAMA, 285, 2995–3002.
Mota, F., et al. (1999). The antigen-presenting environment in normal and human papillomavirus
(HPV)-related premalignant cervical epithelium. Clin Exp Immunol, 116, 33–40.
Munoz, N., et al. (1993). Risk factors for cervical intraepithelial neoplasia grade III/carcinoma in situ
in Spain and Colombia. Cancer Epidemiol Biomarkers Prev, 2, 423–31.
Munoz, N., et al. (1996). Difficulty in elucidating the male role in cervical cancer in Colombia, a high
risk area for the disease. J Natl Cancer Inst, 88, 1068–75.
Nakao, Y., et al. (1996).Malignant transformation of human ectocervical cells immortalized by HPV
18: in vitro model of carcinogenesis by cigarette smoke. Carcinogenesis, 17(3), 577–83.
Ngelangel, C., et al. (1998). Causes of cervical cancer in the Philippines: a case-control study. J Natl
Cancer Inst, 90, 43–9.
Olsen, A. O., et al. (1995). Human papillomavirus and cervical intraepithelial neoplasia grads II-III: A
population-based case-control study. Int J Cancer, 61, 312–15.
Olsen, A.O., et al. (1998). Combined effect of smoking and HPV 16 infection in cervical carcinogenesis.
Epidemiology, 9, 346–9.
Palan, P., et al. (1996). Plasma levels of β-carotene, lycopene, canthaxanthin, retinol and α- and
τ-tocopherol in cervical epithelial neoplasia and cancer. Clinical Cancer Research, 2, 181–5.
Parazzini, F., et al. (1988). Risk factors for adenocarcinoma of the cervix. Br J Cancer, 57, 201–4.
Penn, I. (1986). Cancers of the anogenital region in renal transplant recipients. Cancer, 58, 611.
Petry, K. U., et al. (2003). Inclusion of HPV testing in routine cervical cancer screening for women
above 29 years in Germany: results for 8466 patients. Br J Cancer, 88, 1570–7.
Phillips, A. N. and Davey Smith, G. (1994). Cigarette smoking as a potential cause of cervical cancer:
has confounding been controlled? Int J Epidemiol, 23, 42–9.